Using almost $30 million in funding, an all-in-one vaccine is being developed to bring new protection against a range of new and existing coronavirus variants.
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
A Phase 1 clinical trial of a universal flu vaccine has started inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Maryland.
Gaspary Mwanyika from the SACIDS Foundation for One Health, Sokoine University of Agriculture, Tanzania details the importance of genomic characterisation in the control of dengue.
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
This ‘unusual’ monkeypox outbreak has been found to be larger and more widespread than previous outbreaks outside of Africa, and health experts propose better preparation.
The WHO licensing agreement with the Medicines Patent Pool (MPP) and US National Institutes of Health (NIH) should improve access to some COVID health technologies, like early-stage vaccines and diagnostic tools.
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
